PL1905452T3 - Środek do zapobiegania lub leczenia jaskry - Google Patents
Środek do zapobiegania lub leczenia jaskryInfo
- Publication number
- PL1905452T3 PL1905452T3 PL06780961T PL06780961T PL1905452T3 PL 1905452 T3 PL1905452 T3 PL 1905452T3 PL 06780961 T PL06780961 T PL 06780961T PL 06780961 T PL06780961 T PL 06780961T PL 1905452 T3 PL1905452 T3 PL 1905452T3
- Authority
- PL
- Poland
- Prior art keywords
- glaucoma
- prevention
- agent
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005203352 | 2005-07-12 | ||
PCT/JP2006/313740 WO2007007737A1 (ja) | 2005-07-12 | 2006-07-11 | 緑内障を予防又は治療する薬剤 |
EP06780961.6A EP1905452B1 (en) | 2005-07-12 | 2006-07-11 | Agent for prevention or treatment of glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1905452T3 true PL1905452T3 (pl) | 2013-11-29 |
Family
ID=37637126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06780961T PL1905452T3 (pl) | 2005-07-12 | 2006-07-11 | Środek do zapobiegania lub leczenia jaskry |
Country Status (11)
Country | Link |
---|---|
US (1) | US8193193B2 (pl) |
EP (1) | EP1905452B1 (pl) |
JP (1) | JP4972552B2 (pl) |
KR (1) | KR101333990B1 (pl) |
CN (1) | CN101198355B (pl) |
DK (1) | DK1905452T3 (pl) |
ES (1) | ES2416334T3 (pl) |
HR (1) | HRP20130876T1 (pl) |
PL (1) | PL1905452T3 (pl) |
PT (1) | PT1905452E (pl) |
WO (1) | WO2007007737A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007026664A1 (ja) | 2005-08-30 | 2007-03-08 | Asahi Kasei Pharma Corporation | スルホンアミド化合物 |
US8415372B2 (en) | 2007-02-27 | 2013-04-09 | Asahi Kasei Pharma Corporation | Sulfonamide compound |
AU2008220104B2 (en) | 2007-02-28 | 2012-09-27 | Asahi Kasei Pharma Corporation | Sulfonamide derivative |
CN101730690B (zh) | 2007-07-02 | 2013-01-16 | 旭化成制药株式会社 | 磺酰胺化合物及其结晶 |
ES2684351T3 (es) * | 2011-02-04 | 2018-10-02 | Kowa Co., Ltd. | Terapia farmacológica para prevenir o tratar glaucoma |
JP2013129604A (ja) * | 2011-12-20 | 2013-07-04 | Kowa Co | 緑内障治療薬を含有する徐放性フィルム製剤 |
JP2013129605A (ja) * | 2011-12-20 | 2013-07-04 | Kowa Co | 緑内障治療薬を含有する安定なフィルム製剤 |
JP2015229671A (ja) * | 2014-06-06 | 2015-12-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 網膜色素上皮細胞保護剤 |
US10034885B2 (en) | 2014-09-24 | 2018-07-31 | Kowa Company, Ltd. | Corneal thickness modulating agent |
PT3199161T (pt) * | 2014-09-25 | 2022-02-08 | Kowa Co | Preparação farmacêutica |
HUE048790T2 (hu) | 2014-09-25 | 2020-09-28 | Kowa Co | Vizes készítmény |
KR20160108121A (ko) | 2015-03-06 | 2016-09-19 | 코와 가부시키가이샤 | 수성 조성물 |
TWI699207B (zh) * | 2015-08-31 | 2020-07-21 | 日商興和股份有限公司 | 拉巴斯吉之用於製造眼壓下降增強劑之用途 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2554816A (en) * | 1950-04-04 | 1951-05-29 | American Cyanamid Co | Heterocyclic sulfonamides and methods of preparation thereof |
US3885047A (en) * | 1972-06-16 | 1975-05-20 | Mead Johnson & Co | Ocular hypotensive process employing dextrorotatory phenethanolamines |
US4483864A (en) * | 1983-02-04 | 1984-11-20 | University Of Iowa Research Foundation | Non-classical topical treatment for glaucoma |
JPS61227581A (ja) | 1985-04-02 | 1986-10-09 | Asahi Chem Ind Co Ltd | 血管拡張剤 |
US4797413A (en) * | 1986-05-14 | 1989-01-10 | Merck & Co., Inc. | Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use |
EP0286903B2 (en) | 1987-04-03 | 2000-03-29 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
US5153192A (en) | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
JP4316794B2 (ja) | 1997-10-22 | 2009-08-19 | 株式会社デ・ウエスタン・セラピテクス研究所 | イソキノリン誘導体及び医薬 |
JP4212149B2 (ja) | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
AU5198199A (en) | 1998-08-17 | 2000-03-06 | Senju Pharmaceutical Co., Ltd. | Preventives/remedies for glaucoma |
US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
PT1270570E (pt) | 2000-03-16 | 2006-10-31 | Mitsubishi Pharma Corp | Composto de amida e sua utilizacao |
US20030018079A1 (en) | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
US7442686B2 (en) * | 2001-04-12 | 2008-10-28 | Bioaxone Therapeutique Inc. | Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions |
MXPA04005674A (es) * | 2001-12-12 | 2004-10-15 | Pharmacia Corp | Metodo para tratar trastornos oftalmicos con antagonistas epoxi-esteroidales del receptor de aldosterona. |
CA2472619A1 (en) | 2002-01-10 | 2003-07-24 | Bayer Corporation | Fused pyrimidine derivates as rho-kinase inhibitors |
WO2003062227A1 (en) | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
EP1515974A4 (en) * | 2002-06-17 | 2007-02-28 | Merck & Co Inc | NOVEL MAXI K CHANNEL BLOCKERS, METHODS OF USE, AND METHODS OF MANUFACTURING THE SAME |
JP4482726B2 (ja) * | 2002-08-29 | 2010-06-16 | 参天製薬株式会社 | Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 |
AU2003257588A1 (en) * | 2002-08-29 | 2004-03-19 | Santen Pharmaceutical Co., Ltd. | REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
CA2400996A1 (en) | 2002-09-03 | 2004-03-03 | Lisa Mckerracher | 1,4-substituted cyclohexane derivatives |
WO2004039796A1 (de) | 2002-10-28 | 2004-05-13 | Bayer Healthcare Ag | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren |
WO2004045644A1 (ja) | 2002-11-18 | 2004-06-03 | Santen Pharmaceutical Co., Ltd. | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 |
JP2004250410A (ja) | 2003-02-21 | 2004-09-09 | Mitsubishi Pharma Corp | 腎臓における虚血−再灌流障害の治療剤 |
EP1606266A4 (en) | 2003-03-21 | 2008-06-25 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
WO2005037197A2 (en) | 2003-10-06 | 2005-04-28 | Glaxo Group Limited | Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
US20070123561A1 (en) | 2003-10-06 | 2007-05-31 | Dennis Lee | Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors |
JP2007507549A (ja) | 2003-10-06 | 2007-03-29 | グラクソ グループ リミテッド | キナーゼ阻害剤としての1,6,7−三置換アザベンゾイミダゾールの調製 |
JP2007008816A (ja) | 2003-10-15 | 2007-01-18 | Ube Ind Ltd | 新規イソキノリン誘導体 |
EP1679308B1 (en) | 2003-10-15 | 2013-07-24 | Ube Industries, Ltd. | Novel indazole derivative |
JP2007015928A (ja) | 2003-10-15 | 2007-01-25 | Ube Ind Ltd | 新規オレフィン誘導体 |
WO2005099691A1 (en) * | 2004-03-31 | 2005-10-27 | Pharmacia & Upjohn Company Llc | Composition for treating elevated intraocular pressure |
CA2583593A1 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
US20060142270A1 (en) * | 2004-12-23 | 2006-06-29 | Kowa Co., Ltd. | Preventing or treating agent for glaucoma |
-
2006
- 2006-07-11 WO PCT/JP2006/313740 patent/WO2007007737A1/ja active Application Filing
- 2006-07-11 ES ES06780961T patent/ES2416334T3/es active Active
- 2006-07-11 KR KR1020087000643A patent/KR101333990B1/ko active Protection Beyond IP Right Term
- 2006-07-11 CN CN2006800215238A patent/CN101198355B/zh not_active Expired - Fee Related
- 2006-07-11 US US11/995,052 patent/US8193193B2/en not_active Expired - Fee Related
- 2006-07-11 PL PL06780961T patent/PL1905452T3/pl unknown
- 2006-07-11 PT PT67809616T patent/PT1905452E/pt unknown
- 2006-07-11 JP JP2007524652A patent/JP4972552B2/ja active Active
- 2006-07-11 DK DK06780961.6T patent/DK1905452T3/da active
- 2006-07-11 EP EP06780961.6A patent/EP1905452B1/en active Active
-
2013
- 2013-09-18 HR HRP20130876TT patent/HRP20130876T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
KR101333990B1 (ko) | 2013-11-27 |
EP1905452B1 (en) | 2013-06-19 |
CN101198355A (zh) | 2008-06-11 |
ES2416334T3 (es) | 2013-07-31 |
US20090118299A1 (en) | 2009-05-07 |
EP1905452A4 (en) | 2012-02-15 |
CN101198355B (zh) | 2010-11-10 |
JPWO2007007737A1 (ja) | 2009-01-29 |
PT1905452E (pt) | 2013-07-16 |
HRP20130876T1 (hr) | 2013-10-25 |
KR20080027827A (ko) | 2008-03-28 |
JP4972552B2 (ja) | 2012-07-11 |
EP1905452A1 (en) | 2008-04-02 |
DK1905452T3 (da) | 2013-07-01 |
US8193193B2 (en) | 2012-06-05 |
WO2007007737A1 (ja) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1905452T3 (pl) | Środek do zapobiegania lub leczenia jaskry | |
HUS1500034I1 (hu) | Indolidon-származékok fibrózisos betegségek kezelésére vagy megelõzésére | |
ZA200709727B (en) | Compounds and methods for the treatment of prevention of flavivirus infections | |
ZA200801706B (en) | Methods and compositions for the prevention and treatment of kidney disease | |
IL191283A (en) | Compositions for treating eye irregularities | |
IL187999A0 (en) | Compositions for the treatment of persistent infections | |
ZA200800452B (en) | Methods and compositions for the prevention and treatment of kidney disease | |
IL190779A0 (en) | Compositions for treatment of eye diseases | |
PL1884234T3 (pl) | Środek profilaktyczny lub leczniczy w zaburzeniach rogówkowych i spojówkowych | |
IL187565A0 (en) | Compositions and methods for the treatment or prevention of chemoresistant neoplasia | |
ZA200708819B (en) | Methods and compositions for the prevention and treatment of kidney disease | |
ZA200800448B (en) | Methods and compositions for the prevention and treatment of inflammatory disease | |
EP1950209A4 (en) | TREATMENT AGENT FOR CIRCULATORY INSUFFICIENCY | |
EP1915998A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL OR CONJUNCTIVAL DISEASE | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
ZA200708033B (en) | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | |
EP1867640A4 (en) | MEANS FOR TREATING SOLID TUMORS | |
PL2056799T3 (pl) | Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi | |
IL188787A (en) | Preparations for the treatment of diabetic eye complications | |
EP2231146A4 (en) | Pharmaceutical composition for the treatment and prevention of glaucoma | |
EP1799849A4 (en) | AGENTS FOR THE TREATMENT OR PREVENTION OF ALLERGIC DISEASES | |
EP1857119A4 (en) | AGENT FOR THE PREVENTION / TREATMENT OF NEURODEGENERATIVE DISEASE | |
EP1865952A4 (en) | COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES | |
HUP0500947A2 (en) | Composition for treatment of paradontosis | |
ZA200903626B (en) | DMAE as sole agent for the treatment of mild cognitive impairment |